Federal Register / Vol. 83, No. 166 / Monday, August 27, 2018 / Notices 43685 

9This consists of an estimated $9,302,400 for 

automated telephone cost ($1.36 per request × 6.84 

million requests) and an estimated $4,617,000 

($0.15 per request × 30.78 million requests) for 

internet web service cost. Per unit cost estimates are 

based on staff’s knowledge of the industry. 

that consumer reporting agencies will 

use third-party contractors (instead of 

their own employees) to increase the 

capacity of their systems. Because of the 

way these contracts are typically 

established, these costs will likely be 

incurred on a continuing basis, and will 

be calculated based on the number of 

requests handled by the systems. Staff 

estimates that the total annual amount 

to be paid for services delivered under 

these contracts is $13,919,400.9

H. Net Burden for FTC, After 50:50 Split 

After halving the updated estimates to 

split the PRA burden with the CFPB 

regarding the Rule, the FTC’s burden 

totals are 214,538 hours, $4,246,441 in 

associated labor costs, and $6,959,700 in 

non-labor/capital costs. 

Request for Comments 

You can file a comment online or on 

paper. For the FTC to consider your 

comment, we must receive it on or 

before October 26, 2018. Write 

‘‘Paperwork Reduction Act: FTC File 

No. P072108’’ on your comment. Your 

comment—including your name and 

your state—will be placed on the public 

record of this proceeding, including, to 

the extent practicable, on the public 

Commission website, at https://

www.ftc.gov/policy/public-comments. 

Postal mail addressed to the 

Commission is subject to delay due to 

heightened security screening. As a 

result, we encourage you to submit your 

comments online. To make sure that the 

Commission considers your online 

comment, you must file it at https://

ftcpublic.commentworks.com/ftc/ 

regulationVsubpartNpra by following 

the instructions on the web based form. 

If this Notice appears at https://

www.regulations.gov, you also may file 

a comment through that website. 

If you file your comment on paper, 

write ‘‘Paperwork Reduction Act: FTC 

File No. P072108’’ on your comment 

and on the envelope, and mail it to the 

following address: Federal Trade 

Commission, Office of the Secretary, 

600 Pennsylvania Avenue NW, Suite 

CC–5610 (Annex J), Washington, DC 

20580, or deliver your comment to the 

following address: Federal Trade 

Commission, Office of the Secretary, 

Constitution Center, 400 7th Street SW, 

5th Floor, Suite 5610 (Annex J), 

Washington, DC 20024. If possible, 

submit your paper comment to the 

Commission by courier or overnight 

service. 

Because your comment will be placed 

on the publicly accessible FTC website 

at https://www.ftc.gov, you are solely 

responsible for making sure that your 

comment does not include any sensitive 

or confidential information. In 

particular, your comment should not 

include any sensitive personal 

information, such as your or anyone 

else’s Social Security number; date of 

birth; driver’s license number or other 

state identification number, or foreign 

country equivalent; passport number; 

financial account number; or credit or 

debit card number. You are also solely 

responsible for making sure that your 

comment does not include any sensitive 

health information, such as medical 

records or other individually 

identifiable health information. In 

addition, your comment should not 

include any ‘‘trade secret or any 

commercial or financial information 

which . . . . is privileged or 

confidential’’—as provided by Section 

6(f) of the FTC Act, 15 U.S.C. 46(f), and 

FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)— 

including in particular competitively 

sensitive information such as costs, 

sales statistics, inventories, formulas, 

patterns, devices, manufacturing 

processes, or customer names. 

Comments containing material for 

which confidential treatment is 

requested must be filed in paper form, 

must be clearly labeled ‘‘Confidential,’’ 

and must comply with FTC Rule 4.9(c). 

In particular, the written request for 

confidential treatment that accompanies 

the comment must include the factual 

and legal basis for the request, and must 

identify the specific portions of the 

comment to be withheld from the public 

record. See FTC Rule 4.9(c). Your 

comment will be kept confidential only 

if the General Counsel grants your 

request in accordance with the law and 

the public interest. Once your comment 

has been posted on the public FTC 

website—as legally required by FTC 

Rule 4.9(b)—we cannot redact or 

remove your comment from the FTC 

website, unless you submit a 

confidentiality request that meets the 

requirements for such treatment under 

FTC Rule 4.9(c), and the General 

Counsel grants that request. 

Visit the Commission website at 

https://www.ftc.gov to read this Notice. 

The FTC Act and other laws that the 

Commission administers permit the 

collection of public comments to 

consider and use in this proceeding as 

appropriate. The Commission will 

consider all timely and responsive 

public comments that it receives on or 

before October 26, 2018. You can find 

more information, including routine 

uses permitted by the Privacy Act, in 

the Commission’s privacy policy, at 

https://www.ftc.gov/site-information/ 

privacy-policy. 

Heather Hippsley, 

Acting Principal Deputy General Counsel. 

[FR Doc. 2018–18448 Filed 8–24–18; 8:45 am] 

BILLING CODE 6750–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Toxic Substance and 

Disease Registry 

[60Day–18–18AUZ; Docket No. ATSDR– 

2018–0008] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Agency for Toxic Substances 

and Disease Registry (ATSDR), 

Department of Health and Human 

Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Agency for Toxic 

Substances and Disease Registry 

(ATSDR), as part of its continuing effort 

to reduce public burden and maximize 

the utility of government information, 

invites the general public and other 

Federal agencies the opportunity to 

comment on a proposed and/or 

continuing information collection, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on a proposed information 

collection project titled ‘‘Human Health 

Effects of Drinking Water Exposures to 

Per- and Polyfluoroalkyl Substances 

(PFAS) at Pease International Tradeport, 

Portsmouth, NH (The Pease Study).’’ 

The purpose of this research is to use 

sound study methods to see if drinking 

water exposure to PFAS is related to 

health outcomes in this New Hampshire 

community. 

DATES: ATSDR must receive written 

comments on or before October 26, 

2018. 

ADDRESSES: You may submit comments, 

identified by Docket No. ATSDR–2018– 

0008 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 


amozie on DSK3GDR082PROD with NOTICES1
43686 Federal Register / Vol. 83, No. 166 / Monday, August 27, 2018 / Notices 

Docket Number. ATSDR will post, 

without change, all relevant comments 

to Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffery M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses. 

5. Assess information collection costs. 

Proposed Project 

Human Health Effects of Drinking 

Water Exposures to Per- and 

Polyfluoroalkyl Substances (PFAS) at 

Pease International Tradeport, 

Portsmouth, NH (The Pease Study)— 

NEW—Agency for Toxic Substances and 

Disease Registry (ATSDR). 

Background and Brief Description 

Per- and polyfluoroalkyl substances 

(PFAS) are a family of environmentally 

and biologically persistent chemicals 

used in industrial applications such as 

aqueous film-forming foam (AFFF), 

used to extinguish flammable liquid 

fires. Since the 1970s, military bases in 

the U.S. have used AFFF with PFAS 

constituents for firefighting training as 

well as to extinguish fires. At some 

military bases, AFFF use has resulted in 

the migration of PFAS chemicals 

through soils to ground water and/or 

surface water sources of drinking water 

for bases and/or surrounding 

communities. In 2016, the U.S. 

Environmental Protection Agency 

(USEPA) issued a lifetime health 

advisory level of 0.07 total micrograms 

of perfluorooctanoate (PFOA) and 

perfluorooctane sulfonate (PFOS) 

combined per liter of drinking water 

(mg/L). In response to growing 

awareness of the extent of PFAS 

contamination across the U.S., Section 

8006 of the Consolidated 

Appropriations Act, 2018, authorized 

the Agency for Toxic Substances and 

Disease Registry (ATSDR) to conduct a 

study on the human health effects of 

PFAS contamination in drinking water. 

In response, ATSDR is requesting a 

three-year Paperwork Reduction Act 

(PRA) clearance for the Pease Study, 

which will serve as a proof-of-concept 

model for a national multi-site study of 

PFAS health effects. The existence of a 

large body of state and local 

environmental monitoring and 

population blood testing data makes the 

Pease community in Portsmouth, NH, 

particularly suitable as ATSDR’s initial 

PFAS research study site. From 

approximately 1970 until 1991, the Air 

Force used AFFF for firefighting and 

training at Pease Air Force Base. The 

base closed in 1991, and was converted 

to a large business and aviation 

industrial park in 1993, the Pease 

International Tradeport. In 2014, PFAS 

drinking water concentrations were 

detected (0.35 mg/L PFOA and 2.4 mg/L 

PFOS) at levels well above what was to 

become the USEPA lifetime health 

advisory level (0.07 mg/L PFOA/PFOS). 

In 2015–7, the New Hampshire 

Department of Health and Human 

Services (NH DHHS) offered a PFAS 

blood testing program to the 

community. The blood testing program 

showed that the Pease population had 

concentrations of some types of PFAS 

that were two to three times higher than 

national estimates. 

The Pease Study will be crosssectional in design, drawing from a 

convenience sample of people with and 

without exposure to PFAScontaminated drinking water from 

Pease. The main goals of the study are 

to: (1) Evaluate the study procedures 

and methods to identify any issues that 

need to be addressed before embarking 

on a national multi-site study; and (2) 

examine associations between health 

outcomes and measured and historically 

reconstructed serum levels of PFAS. 

ATSDR will examine the association 

between PFAS compounds and lipids, 

renal function and kidney disease, 

thyroid hormones and disease, liver 

function and disease, glycemic 

parameters and diabetes, as well as 

immune response and function in both 

children and adults. In addition, ATSDR 

will investigate if PFAS is related to 

differences in sex hormones and sexual 

maturation, vaccine response, and 

neurobehavioral outcomes in children. 

In adults, additional outcomes of 

interest include cardiovascular disease, 

osteoarthritis, osteoporosis, 

endometriosis, and autoimmune 

disease. Adults will be 18 years or older, 

and children will be 4–17 years of age 

at enrollment. 

In total, ATSDR seeks to enroll 1,625 

participants (1,100 adults and 525 

children and their parents). Annualized 

estimates are 542 participants (367 

adults and 175 children). 

For the exposure group (n=1,350), 

ATSDR will enroll 1,000 adults and 350 

children. Annualized estimates are 450 

exposed participants (333 adults and 

117 children). Eligible participants had 

to work at, live on, or attend childcare 

at the former Pease Air Force Base or the 

Pease International Tradeport, or live in 

a nearby home that was served by a 

PFAS-contaminated private well. 

Drinking water exposures must have 

occurred at some time between 2004 

and May 2014, after which remediation 

of the public water supply occurred. 

For the referent group (n=275), 

ATSDR will enroll 100 adults and 175 

children. Annualized estimates are 92 

referent participants (34 adults and 58 

children). Eligible participants, never 

exposed to PFAS-contaminated drinking 

water from Pease, will come from other 

areas of Portsmouth, NH. Birth mothers 

of referent children likewise must never 

have had PFAS drinking water 

exposure. 

ATSDR will recruit, screen for 

eligibility, and enroll in three waves. 

The exposure group will be recruited in 

Waves One and Two. ATSDR estimates 

that 90% of the exposure group will be 


amozie on DSK3GDR082PROD with NOTICES1
Federal Register / Vol. 83, No. 166 / Monday, August 27, 2018 / Notices 43687 

enrolled in Wave 1 (n=1,215, or 405 per 

year), that is, will be past participants of 

the 2015–7 NH DHHS PFAS blood 

testing program. NH DHHS will assist 

ATSDR by sending out letters of 

invitation to its former blood testing 

program participants. To achieve the 

desired sample size, the other 10 

percent of the exposure group (n=135, 

or 45 per year) will be recruited in Wave 

2. These will be people who were 

eligible for the PFAS blood testing 

program but did not take part. The 

referent group will be recruited in Wave 

Three (n=275, or 92 per year), which 

can occur concurrently with Wave 1 and 

Wave 2. Wave 2 and Wave 3 recruits 

will call to volunteer after ATSDR opens 

those waves to enrollment. 

To restrict this study to drinking 

water exposures, any adult 

occupationally exposed to PFAS will 

not be eligible for the study (i.e. ever 

firefighters or in chemical manufacture). 

Likewise, children whose birth mothers 

were occupationally exposed will not be 

eligible. This restriction applies to both 

the exposure and the referent group. 

ATSDR assumes that 5% of the people 

who volunteer will not meet eligibility 

requirements. ATSDR will screen the 

1,578 people from the NH DHHS PFAS 

blood testing program in Wave One 

(n=526 per year). ATSDR will screen at 

least 142 exposed people in Wave 2 (or 

47 per year), and at least 289 unexposed 

people in Wave 3 (or 96 per year). This 

will require an annual time burden of 

124 hours for eligibility screening. 

At enrollment, ATSDR will obtain 

adult consent, parental permission, and 

child assent before data collection 

begins. Each child will enroll with a 

parent, who ideally will be the child’s 

birth mother, as ATSDR will ask details 

about the child’s exposure, pregnancy, 

and breastfeeding history. 

For each participant, ATSDR will take 

body measures, collect blood and urine 

samples for chemical and biomarker 

analysis, and administer a questionnaire 

on exposures and medical history. For 

purposes of burden estimation, ATSDR 

assumes that 20% of parents will also 

enroll as adults; therefore, 420 parents 

will take the child questionnaire long 

form (n=140 per year), while 105 

parents will take the short form to 

reduce burden (n=35 per year). Parents 

and children will also complete 

assessments of the child’s attention and 

behaviors. After eligibility screening, 

the annual time burden for participation 

in the study is 58 hours for adults and 

208 hours for children and their parents. 

ATSDR will ask for permission to 

compare adults’ and children’s medical 

histories with their medical records. 

ATSDR will also ask for permission to 

check children’s school records to 

compare their behavioral assessment 

results. The annual time burden for 

medical and educational record 

abstraction is estimated to be 125 hours 

for adult records and 118 hours for 

children’s records. 

The total annualized time burden 

requested is 1,189 hours. There is no 

cost to the respondents other than their 

time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

Pease Study Participants Wave One Eligibility Screening Script ................. 526 1 10/60 88 

Wave Two Eligibility Screening Script ................. 47 1 15/60 12 

Wave Three Eligibility Screening Script .............. 96 1 15/60 24 

Appointment Reminder Telephone Script ........... 542 1 5/60 45 

Update Contact Information Hardcopy Form ...... 542 1 5/60 45 

Medication List ..................................................... 542 1 3/60 27 

Body and Blood Pressure Measures Form ......... 542 1 5/60 45 

Blood Draw and Urine Collection Form .............. 542 1 10/60 90 

Adult Questionnaire ............................................. 367 1 30/60 184 

Child Questionnaire—Long Form ........................ 140 1 30/60 70 

Child Questionnaire—Short Form ....................... 35 1 15/60 9 

Parent Neurobehavioral Test Battery .................. 175 1 15/60 44 

Child Neurobehavioral Test Battery .................... 175 1 90/60 263 

Education Specialists .... Child School Record Abstraction Form ............... 15 12 20/60 60 

Medical Record Specialists.Medical Record Abstraction Form—Adult ........... 25 15 20/60 125 

Medical Record Abstraction Form—Child ........... 25 7 20/60 58 

Total ........................ .............................................................................. ........................ ........................ ........................ 1,189 

Jeffrey M. Zirger, 

Acting Chief, Information Collection Review 

Office, Office of Scientific Integrity, Office 

of the Associate Director for Science, Office 

of the Director, Centers for Disease Control 

and Prevention. 

[FR Doc. 2018–18446 Filed 8–24–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[CDC–2017–0104; Docket Number NIOSH– 

304] 

Final National Occupational Research 

Agenda for Traumatic Injury 

Prevention 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC), 

Department of Health and Human 

Services (HHS). 

ACTION: Notice of availability. 

SUMMARY: NIOSH announces the 

availability of the final National 

Occupational Research Agenda for 

Traumatic Injury Prevention. 

DATES: The final document was 

published on August 20, 2018 on the 

CDC website. 

ADDRESSES: The document may be 

obtained at the following link: https:// 


amozie on DSK3GDR082PROD with NOTICES1